131 related articles for article (PubMed ID: 32794077)
41. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat.
van Beijsterveldt L; Geerts R; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
Arzneimittelforschung; 2004; 54(2):85-94. PubMed ID: 15038457
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics and tissue distributions of veratric acid after intravenous administration in rats.
Peng YS; Liu LJ; Zhao C; Yang X; Liu C; Wang RF
Chin J Nat Med; 2015 Jul; 13(7):535-9. PubMed ID: 26233844
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
[TBL] [Abstract][Full Text] [Related]
45. Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.
Shen C; Qian Z; Chen R; Meng X; Hu T; Chen Z; Li Y; Huang C; Hu C; Li J
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):675-688. PubMed ID: 26254910
[TBL] [Abstract][Full Text] [Related]
46. Investigation of nimodipine pharmacokinetics in Chinese patients with acute subarachnoid haemorrhage.
Kumana CR; Kou M; Yu YL; Fong KY; Fung CF; Chang CM; Mück W; Lauder IJ
Eur J Clin Pharmacol; 1993; 45(4):363-6. PubMed ID: 8299671
[TBL] [Abstract][Full Text] [Related]
47. Cyclosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats.
Liu XD; Pan GY; Xie L; Hou YY; Lan W; Su Q; Liu GQ
Acta Pharmacol Sin; 2002 Mar; 23(3):225-9. PubMed ID: 11918846
[TBL] [Abstract][Full Text] [Related]
48. Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures.
Larkin JG; Thompson GG; Scobie G; Forrest G; Drennan JE; Brodie MJ
Epilepsia; 1992; 33(4):760-9. PubMed ID: 1628595
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics, bioavailability and tissue distribution study of JCC-02, a novel N-methyl-d-aspartate (NMDA) receptor inhibitor, in rats by LC-MS/MS.
Yang T; Shi Y; Lin C; Yan C; Zhang D; Lin J
Eur J Pharm Sci; 2019 Apr; 131():146-152. PubMed ID: 30776467
[TBL] [Abstract][Full Text] [Related]
50. Formulation and evaluation of nimodipine-loaded lipid microspheres.
Yu J; He HB; Tang X
J Pharm Pharmacol; 2006 Nov; 58(11):1429-35. PubMed ID: 17132204
[TBL] [Abstract][Full Text] [Related]
51. The influence of age on the pharmacokinetics of nimodipine.
Mück W; Breuel HP; Kuhlmann J
Int J Clin Pharmacol Ther; 1996 Jul; 34(7):293-8. PubMed ID: 8832305
[TBL] [Abstract][Full Text] [Related]
52. Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice.
Moreno LCGEAI; Solas M; Martínez-Ohárriz MC; Muñoz E; Santos-Magalhães NS; Ramirez MJ; Irache JM
Int J Pharm; 2018 May; 543(1-2):245-256. PubMed ID: 29604372
[TBL] [Abstract][Full Text] [Related]
53. In vitro and in vivo evaluation of hypothermia on pharmacokinetics and pharmacodynamics of nimodipine in rabbits.
Fei YX; Zhang TH; Zhao J; Ren H; Du YN; Yu CL; Wang Q; Li S; Ren TL; Jian Q; Fei SY; Zhang ZQ; Zhang Y
J Int Med Res; 2018 Jan; 46(1):335-347. PubMed ID: 28851258
[TBL] [Abstract][Full Text] [Related]
54. Toxicity of zinc oxide nanoparticles in rats treated by two different routes: single intravenous injection and single oral administration.
Choi J; Kim H; Kim P; Jo E; Kim HM; Lee MY; Jin SM; Park K
J Toxicol Environ Health A; 2015; 78(4):226-43. PubMed ID: 25674826
[TBL] [Abstract][Full Text] [Related]
55. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
Pestieau SR; Stuart OA; Sugarbaker PH
Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
[TBL] [Abstract][Full Text] [Related]
56. Enantioselective pharmacokinetics of homochlorcyclizine: disposition of (+)- and (-)-homochlorcyclizine after intravenous and oral administration of racemic homochlorcyclizine to rats.
Nishikata M; Nakai A; Fushida H; Miyake K; Arita T; Iseki K; Miyazaki K
J Pharm Pharmacol; 1994 Jul; 46(7):591-5. PubMed ID: 7996389
[TBL] [Abstract][Full Text] [Related]
57. Studies on concentration-time profiles of nimodipine enantiomers following intravenous and oral administration of nimodipine in patients with subarachnoid hemorrhage.
Wanner-Olsen H; Gaarskaer FB; Mikkelsen EO; Jakobsen P; Voldby B
Chirality; 2000 Oct; 12(9):660-4. PubMed ID: 10984739
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics and tissue distribution of Ebracteolatain A, a potential anti-cancer compound, as determined by an optimized ultra-performance liquid chromatography tandem mass spectrometry method.
Lv L; Liu Y; Li L; Qin FL; Li CJ; Zhou YQ; Zhou YN; Wang H; Jiao Y; Zhao L
J Pharm Biomed Anal; 2019 May; 169():279-287. PubMed ID: 30884326
[TBL] [Abstract][Full Text] [Related]
59. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats.
Li Y; Pan WS; Chen SL; Xu HX; Yang DJ; Chan AS
Drug Dev Ind Pharm; 2006 Apr; 32(4):413-22. PubMed ID: 16638679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
